Adenocarcinoma treatment cost in Spain typically involves essential diagnostics such as a CT scan of the body part ranging from $200 to $400. Surgical interventions like lung cancer surgery cost $40,000 to $70,000, while complex procedures like Whipple surgery run from $25,000 to $45,000. Expenses depend on cancer stage, clinic accreditation, and the specific organ affected. Patients often find 30-50% savings compared to the US. Major medical hubs include Barcelona, Madrid, and Pamplona.
Typical Adenocarcinoma Treatment Costs in Spain
Bookimed Expert Insight: Patients seeking the gold standard in oncology should prioritize JCI-accredited centers like Centro Médico Teknon. It serves 10,000 patients annually and provides advanced diagnostics for high-profile individuals. For complex sarcomas or rare adenocarcinomas, Clinica Universidad de Navarra is best. It maintains a 95% limb preservation rate. Those interested in clinical trials may find zero-cost treatment opportunities at Quironsalud Madrid. For advanced breast cancer protocols, Hospital Quiron Barcelona offers specialized care through its Baselga Institute of Oncology collaboration.
| Turkey | Austria | Spain | |
| Whipple surgery | from $23,000 | from $45,000 | from $25,000 |
| Uterine Trachelectomy | from $5,500 | from $14,500 | from $10,000 |
| Robotic da Vinci prostatectomy | from $17,000 | from $20,000 | from $10,000 |
| Radiation therapy for colorectal cancer | from $7,000 | from $12,000 | from $10,000 |
| Proton-beam therapy | from $70,000 | from $80,000 | from $25,393 |
With over _doctor_3339_years_ of experience, Dr. Lopez Ibor leads the Pediatric Hematology and Oncology Unit at HM Montepríncipe Hospital.
Dr. Luis Madero is a pediatric oncologist with 37 years of experience in treating blood disorders, bone marrow transplant, ablation therapy, and other diseases. He is a member of several associations and has extensive experience in his field.
Dr. Enriqueta Felip is an expert in thoracic oncology. She specializes in lung cancer care and clinical trials. She earned her medical degree and PhD from UAB. Dr. Felip has led research on improving chemotherapy, developing new therapies, using immunotherapy, and understanding resistance to targeted treatments.
She served as a board member of the IASLC from 2017 to 2021 and was Vice-President of SEOM from 2019 to 2021. In 2015, she received the first ESMO Women for Oncology Award. Dr. Felip has written many peer-reviewed articles and book chapters. She is known for her leadership in international oncology societies and clinical research.
Medical Director of the University of Navarra Clinic
Prof. of hematology and hemotherapy